DNA adduct formation by hormonal steroids in vitro

Mutation Research - Genetic Toxicology

Volumn 370, Issue 1, 1996, Pages 49-59

  Seraj, Mohammed Jabed ^a   Umemoto, Atsushi ^a   Tanaka, Masaki ^a   Kajikawa, Aiichiro ^a   Hamada, Kunimi ^a   Monden, Yasumasa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

32P postlabeling; Carcinogenesis; DNA adduct; DNA modification; Steroid hormone

Indexed keywords

ALDOSTERONE; CHOLESTEROL; CORTICOSTERONE; CORTISONE; CORTODOXONE; DEOXYCORTICOSTERONE; DEXAMETHASONE; ESTRADIOL; ESTRIOL; ESTRONE; HORMONE; HYDRALLOSTANE; HYDROCORTISONE; HYDROXYPROGESTERONE; PREDNISOLONE; PROGESTERONE; STEROID; TESTOSTERONE; TETRAHYDROCORTISOL;

ARTICLE; CARCINOGENESIS; COVALENT BOND; DNA ADDUCT; DNA MODIFICATION; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0030586698     PISSN: 01651218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(96)90126-3     Document Type: Article

References (28)

1. [1] Sugimura, T. (1992) Multistep carcinogenesis: A 1992 perspective, Science, 258, 603-607.
2. [2] Sugimura, T., M. Terada, J. Yokota, S. Hirohashi and K. Wakabayashi (1992) Multiple genetic alterations in human carcinogenesis, Environ. Health. Perspect., 98, 5-12.
3. [3] Harris, C.C. (1991) Chemical and physical carcinogenesis: Advances and perspectives for the 1990s, Cancer Res. (Suppl.), 51, 5023s-5044s.
4. [4] Hemminki, K. (1993) DNA adducts, mutations and cancer, Carcinogenesis, 14, 2007-2012.
5. 32P-postlabeling assay. Carcinogenesis, 13, 1053-1074.
6. 32P-postlabeling test for structurally diverse DNA adducts, Carcinogenesis, 7, 1543-1551.
7. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts, Carcinogenesis, 3, 1081-1092.
8. [8] Umemoto, A., A. Kajikawa, M. Tanaka, K. Hamada, M.J. Seraj, A. Kubota, M. Nakayama, T. Kinouchi, Y. Ohnishi, K. Yamashita and Y. Monden (1994) Presence of mucosa-specific DNA adduct in human colon: possible implication for colorectal cancer, Carcinogenesis, 15, 901-905.
9. [9] Hamada, K., A. Umemoto, A. Kajikawa, M. Tanaka, M.J. Seraj, A. Kubota and Y. Monden (1994) Mucosa-specific DNA adducts in human small intestine: A comparison with the colon, Carcinogenesis, 15, 2677-2680.
10. [10] Sekeris, C.E. (1991) Hormonal steroids act as tumour promoters by modulating oncogene expression, J. Cancer Res. Clin. Oncol., 117, 96-101.
11. [11] Liehr, J.G. (1990) Genotoxic effects of estrogens, Mutation Res., 238, 269-276.
12. [12] Hamada, K., A. Umemoto, A. Kajikawa, M.J. Seraj and Y. Monden (1994) In vitro formation of DNA adducts with bile acids, Carcinogenesis, 15, 1911-1915.
13. [13] Liehr, J.G., T.A. Avitts, E. Randerath and K. Randerath (1986) Estrogen-induced endogenous DNA adduction: Possible mechanism of hormonal cancer, Proc. Natl. Acad. Sci. USA, 83, 5301-5305.
14. [14] Topinka, J., U. Andrae, L.R. Schwarz and T. Wolff (1993) Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures, Carcinogenesis, 14, 423-427.
15. [15] Ashburn, S.P., X. Han and J.G. Liehr (1993) Microsomal hydroxylation of 2-and 4-fluroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis, Mol. Pharmacol., 43, 534-541.
16. [16] Liehr, J.G., E.R. Hall, T.A. Avitts, E. Randerath and K. Randerath (1987) Localization of estrogen-induced DNA adducts and cytochrome P-450 activity at the site of renal carcinogenesis in the hamster kidney, Cancer Res., 47, 2156-2159.
17. 32P-Postlabeing analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level, Jpn. J. Cancer Res., 83, 438-444.
18. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C, Mutation Res., 179, 75-88.
19. [19] Lutz, W.K. (1979) In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis, Mutation Res., 65, 289-356.
20. [20] Hemminki, K. (1983) Nucleic acid adducts of chemical carcinogens and mutagens, Arch. Toxicol., 52, 249-285.
21. [21] Swenberg, J.A., F.C. Richardson, J.A. Boucheron and M.C Dyroff (1985) Relationship between DNA adduct formation and carcinogenesis, Environ. Health Perspect., 62, 177-188.
22. [22] Lutz, W.K. (1987) Quantitative evaluation of DNA-binding data in vivo for low-dose extrapolations, Arch. Toxicol. (Suppl.), 11, 66-74.
23. [23] Farber, E. (1983) The multistep nature of cancer development, Cancer Res., 44, 4217-4223.
24. 32P-Postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography, Carcinogenesis, 15, 2061-2064.
25. 32P-postlabelling to investigate DNA adduct formation by bile acids in vitro: lack of evidence for covalent binding, Carcinogenesis, 16, 1489-1491.
26. [26] Bogaert, M.D., P.J. Dierickx, C. Stecca and M.C. Crutzen (1993) Metabolic activation by a supernatant from human hepatoma cells: a possible alternative in mutagenic tests, Mutation Res., 292, 199-204.
27. [27] Dawson, J.R., D.J. Adams and C.R. Wolf (1985) Induction of drug metabolizing enzymes in human liver cell line, Hep G2, FEBS Lett., 183, 219-222.
28. [28] Labruzzo, P., X.F. Yu and J. Dufresne (1989) Induction of aryl hydrocarbon hydroxylase and demonstration of a specific nuclear receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxine in two human hepatoma cell lines, Biochem. Pharmacol., 38, 2339-2348.